Terapia adjuvantă cu imunomodulatori în oncologie
In the field of oncology immunotherapy, remarkable discoveries have been made în recent years. The aim of this paper is to cover recent findings în oncology immunotherapy, including the use of inhibitory T cells, modified T cells, anti-cancer vaccines and anti-B and T antibodies. In veterinary oncol...
Saved in:
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Asociaţia Naţională a Fabricanţilor de Produse de Uz Veterinar
2023-12-01
|
Series: | Medicamentul Veterinar |
Subjects: | |
Online Access: | http://www.veterinarypharmacon.com/docs/2609-2023_VD_17(2)_ART.1.ROM.pdf |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | In the field of oncology immunotherapy, remarkable discoveries have been made în recent years. The aim of this paper is to cover recent findings în oncology immunotherapy, including the use of inhibitory T cells, modified T cells, anti-cancer vaccines and anti-B and T antibodies. In veterinary oncology, immunotherapy is increasingly used due to impressive results. Modified T-cell therapy has demonstrated remarkable tumour control and regression în human subjects, and anticancer vaccines have recently demonstrated long disease-free periods and increased survival time în dogs with lymphoma. Thus, due to the clinical effects obtained, immunomodulators are successfully used în veterinary oncology therapy. |
---|---|
ISSN: | 1843-9527 2069-2463 |